GlycoMimetics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GlycoMimetics and other ETFs, options, and stocks.

About GLYC

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates.

CEO

Harout Semerjian

CEOHarout Semerjian

Employees

Employees52

Headquarters

Rockville, Maryland

HeadquartersRockville, Maryland

Founded

2003

Founded2003

Employees

Employees52

GLYC Key Statistics

Market cap

105.90M

Market cap105.90M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.14M

Average volume1.14M

High today

$2.05

High today$2.05

Low today

$2.03

Low today$2.03

Open price

$2.05

Open price$2.05

Volume

20.56K

Volume20.56K

52 Week high

$2.43

52 Week high$2.43

52 Week low

$0.51

52 Week low$0.51

GLYC Earnings

-$0.34

-$0.23

-$0.11

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 2, Pre-Market

ActualExpected Mar 2, Pre-Market

GlycoMimetics

Why Robinhood?

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. Show more

GLYC Key Statistics

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates.